Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Abstract Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer, yet factors associated with DCIS initiation, progression to invasive breast cancer, and recurrence of ipsilateral DCIS or invasive breast cancer following treatment remain poorly understood. Understanding how systemic and local microenvironment-related factors influence DCIS biology may improve risk stratification and help to distinguish lesions likely to remain indolent from those at high risk of progressing to invasive breast cancer. We conducted a systematic review and meta-analysis to evaluate associations between breast density, metabolic risk factors, adipocyte-related measures, and background parenchymal enhancement (BPE) with DCIS outcomes. A systematic search identified 35 eligible studies comprising 47,796 new DCIS diagnoses or ipsilateral invasive breast cancer (iIBC) diagnoses. Higher mammographic breast density was consistently associated with increased risk of DCIS initiation across menopausal subgroups (pooled relative effect 2.36; 95% CI 1.79–3.11), with supporting studies generally at low risk of bias. Higher BMI was associated with lower risk of DCIS initiation in premenopausal women (0.74; 95% CI 0.63–0.87) where an opposite but non-significant association was observed in postmenopausal women (1.17; 95% CI 0.99–1.37). Evidence regarding adipocyte-related measures, metabolic risk factors beyond BMI, and recurrence outcomes was limited and heterogeneous. No eligible studies evaluated progression to invasive breast cancer after untreated DCIS. These findings support a role for breast density and adiposity-related factors in early DCIS development. Whereas DCIS initiation has been relatively well-described, evidence regarding progression and recurrence remains sparse, highlighting a critical research gap in improving biologically informed risk stratification in DCIS.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2026-11-14
DOI
https://doi.org/10.1186/s13058-026-02415-4
Primary Topic
Digital Radiography and Breast Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Sofie A. M. Gernaat, Marjanka K. Schmidt, Tanja Alderliesten, Proteeti Bhattacharjee et al.
Breast Cancer Research
Digital Radiography and Breast Imaging
article

Breast density and metabolic factors in DCIS: systematic review and meta-analysis

Sofie A. M. Gernaat, Marjanka K. Schmidt, Tanja Alderliesten, Proteeti Bhattacharjee, Sabine Siesling, Mireille J. M. Broeders, Wesseling Jelle, Esther H. Lips, Ria Wolkorte, Valesca Retel, Ellen Verschuur, H. M. Lenny Verkooijen, Peter Bosman, Stevie van der Mierden, Maya van den Berg, Lisa A. van den Heuvel, Julian J. Weiner, Nanne Nivel Bos, Ritse Mann, Esther de Bekker-Grob, Sara Balduzzi
article en

Abstract

Abstract Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer, yet factors associated with DCIS initiation, progression to invasive breast cancer, and recurrence of ipsilateral DCIS or invasive breast cancer following treatment remain poorly understood. Understanding how systemic and local microenvironment-related factors influence DCIS biology may improve risk stratification and help to distinguish lesions likely to remain indolent from those at high risk of progressing to invasive breast cancer. We conducted a systematic review and meta-analysis to evaluate associations between breast density, metabolic risk factors, adipocyte-related measures, and background parenchymal enhancement (BPE) with DCIS outcomes. A systematic search identified 35 eligible studies comprising 47,796 new DCIS diagnoses or ipsilateral invasive breast cancer (iIBC) diagnoses. Higher mammographic breast density was consistently associated with increased risk of DCIS initiation across menopausal subgroups (pooled relative effect 2.36; 95% CI 1.79–3.11), with supporting studies generally at low risk of bias. Higher BMI was associated with lower risk of DCIS initiation in premenopausal women (0.74; 95% CI 0.63–0.87) where an opposite but non-significant association was observed in postmenopausal women (1.17; 95% CI 0.99–1.37). Evidence regarding adipocyte-related measures, metabolic risk factors beyond BMI, and recurrence outcomes was limited and heterogeneous. No eligible studies evaluated progression to invasive breast cancer after untreated DCIS. These findings support a role for breast density and adiposity-related factors in early DCIS development. Whereas DCIS initiation has been relatively well-described, evidence regarding progression and recurrence remains sparse, highlighting a critical research gap in improving biologically informed risk stratification in DCIS.

Breast Cancer Research
Leiden University Medical Center (NL), The Netherlands Cancer Institute (NL), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
Digital Radiography and Breast Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon